PAR paradigm biopharmaceuticals limited..

Tax loss selling + uncertainty surrounding P3 funding and...

  1. 5,000 Posts.
    lightbulb Created with Sketch. 532
    Tax loss selling + uncertainty surrounding P3 funding and overall poor sentiment could just provide a more attractive entry point for anyone willing to back the science.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
30.0¢
Change
-0.010(3.23%)
Mkt cap ! $116.8M
Open High Low Value Volume
30.0¢ 31.5¢ 30.0¢ $61.94K 201.3K

Buyers (Bids)

No. Vol. Price($)
3 55259 30.0¢
 

Sellers (Offers)

Price($) Vol. No.
31.0¢ 9677 1
View Market Depth
Last trade - 16.10pm 19/06/2025 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.